РЕЗОЛЮЦИЯ СОВЕТА ЭКСПЕРТОВ «ВЫБОР АНТИГИПЕРТЕНЗИВНОЙ ТЕРАПИИ У ПАЦИЕНТОВ С АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИЕЙ И СИНДРОМОМ ОБСТРУКТИВНОГО АПНОЭ СНА»

24 июня 2023 г. в режиме видеоконференции при поддержке ООО «Мерк» состоялось заседание Совета экспертов, посвященное выбору антигипертензивной терапии у пациентов с артериальной гипертензией и синдромом обструктивного апноэ сна.

1. Svedmyr S., Hedner J., Zou D., Parati G., Ryan S., Hein H., Pepin J.L., Tkáčová R., Marrone O., Schiza S., Basoglu O.K., Grote L.; European Sleep Apnea Database (ESADA) study group. Superior hypertension control with betablockade in the European Sleep Apnea Database. J Hypertens. 2021;39(2):292-301. doi: 10.1097/HJH.0000000000002629;

2. Benjafield A.V., Ayas N.T., Eastwood P.R., Heinzer R., Ip M.S.M., Morrell M.J., Nunez C.M., Patel S.R., Penzel T., Pépin J.L., Peppard P.E., Sinha S., Tufik S., Valentine K., Malhotra A. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019;7(8):687-698. doi: 10.1016/S2213-2600(19)30198-5;

3. Mancia G., Kreutz R., Brunström M., Burnier M., Grassi G., Januszewicz A., Muiesan M.L., Tsioufis K., Agabiti-Rosei E., Algharably E.A.E. et al.; Authors/Task Force Members:. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41(12):1874-2071. . doi: 10.1097/HJH.0000000000003480;

4. Ren R., Covassin N., Yang L., Li Y., Zhang Y., Zhou J., Tan L., Li T., Li X., Wang Y., Zhang J., Wing Y.K., Li W., Somers V.K., Tang X. Objective but Not Subjective Short Sleep Duration Is Associated With Hypertension in Obstructive Sleep Apnea. Hypertension. 2018;72(3):610-617. doi: 10.1161/HYPERTENSIONAHA.118.11027;

5. Parati G., Lombardi C., Hedner J., Bonsignore M.R., Grote L., Tkacova R., Lévy P., Riha R., Bassetti C., Narkiewicz K., Mancia G., McNicholas W.T.; EU COST Action B26 members. Recommendations for the management of patients with obstructive sleep apnoea and hypertension. Eur Respir J. 2013;41(3):523-38. doi: 10.1183/09031936.00226711;

6. Kapur V.K., Auckley D.H., Chowdhuri S., Kuhlmann D.C., Mehra R., Ramar K., Harrod C.G. Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017;13(3):479-504. doi: 10.5664/jcsm.6506;

7. Benjafield A.V., Ayas N.T., Eastwood P.R., Heinzer R., Ip M.S.M., Morrell M.J., Nunez C.M., Patel S.R., Penzel T., Pepin J.L., Peppard P.E., Sinha S., Tufik S., Valentine K., Malhotra A. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019;7:687–698. doi: 10.1016/S2213-2600(19)30198-5;

8. Knutson K.L., Wu D., Patel S.R., Loredo J.S., Redline S., Cai J., Gallo L.C., Mossavar-Rahmani Y., Ramos A.R., Teng Y., Daviglus M.L., Zee P.C. Association between sleep timing, obesity, diabetes: the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) Cohort Study. Sleep. 2017;40:4. doi: 10.1093/sleep/zsx014;

9. Oscullo G., Torres G., Campos-Rodriguez F., Posadas T., Reina-González A., Sapiña-Beltrán E., Barbé F., Martinez-Garcia M.A. Resistant/Refractory Hypertension and Sleep Apnoea: Current Knowledge and Future Challenges. J Clin Med. 2019;8(11):1872. doi: 10.3390/jcm8111872;

10. Pedrosa R.P., Drager L.F., Gonzaga C.C., Sousa M.G., de Paula L.K., Amaro A.C., Amodeo C., Bortolotto L.A., Krieger E.M., Bradley T.D., Lorenzi-Filho G. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension. 2011;58(5):811-7. doi: 10.1161/HYPERTENSIONAHA.111.179788;

11. McEvoy R.D., Antic N.A., Heeley E., Luo Y., Ou Q., Zhang X., Mediano O., Chen R., Drager L.F., Liu Z., Chen G., Du B., McArdle N., Mukherjee S., Tripathi M., Billot L., Li Q., Lorenzi-Filho G., Barbe F., Redline S., Wang J., Arima H., Neal B., White D.P., Grunstein R.R., Zhong N., Anderson C.S.; SAVE Investigators and Coordinators. CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea. N Engl J Med. 2016;375 (10):919-31. doi: 10.1056/NEJMoa1606599;

12. Cuspidi C., Tadic M., Sala C., Gherbesi E., Grassi G., Mancia G. Blood Pressure Non-Dipping and Obstructive Sleep Apnea Syndrome: A Meta-Analysis. J Clin Med. 2019;8(9):1367. doi: 10.3390/jcm8091367;

13. Somers V.K., White D.P., Amin R., Abraham W.T., Costa F., Culebras A., Daniels S., Floras J.S., Hunt C.E., Olson L.J., Pickering T.G., Russell R., Woo M., Young T. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol. 2008;52(8):686-717. doi: 10.1016/j.jacc.2008.05.002;

14. Yeghiazarians Y., Jneid H., Tietjens J.R., Redline S., Brown D.L., El-Sherif N., Mehra R., Bozkurt B., Ndumele C.E., Somers V.K. Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021;144(3):e56-e67. doi: 10.1161/CIR.0000000000000988;

15. Williams B., Mancia G., Spiering W., Agabiti Rosei E., Azizi M., Burnier M., Clement D.L., Coca A., de Simone G., Dominiczak A., Kahan T., Mahfoud F., Redon J., Ruilope L., Zanchetti A., Kerins M., Kjeldsen S.E., Kreutz R., Laurent S., Lip G.Y.H., McManus R., Narkiewicz K., Ruschitzka F., Schmieder R.E., Shlyakhto E., Tsioufis C., Aboyans V., Desormais I.; Authors/Task Force Members:. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953-2041. doi: 10.1097/HJH.0000000000001940;

16. Svedmyr S., Hedner J., Zou D., Parati G., Ryan S., Hein H., Pepin J.L., Tkáčová R., Marrone O., Schiza S., Basoglu O.K., Grote L.; European Sleep Apnea Database (ESADA) study group. Superior hypertension control with betablockade in the European Sleep Apnea Database. J Hypertens. 2021;39(2):292-301. doi: 10.1097/HJH.0000000000002629;

17. Simantirakis E.N., Schiza S.I., Marketou M.E., Chrysostomakis S.I., Chlouverakis G.I., Klapsinos N.C., Siafakas N.S., Vardas P.E. Severe bradyarrhythmias in patients with sleep apnoea: the effect of continuous positive airway pressure treatment: a long-term evaluation using an insertable loop recorder. Eur Heart J. 2004;25(12):1070-6. doi: 10.1016/j.ehj.2004.04.017;

18. Glikson M., Nielsen J.C., Kronborg M.B., Michowitz Y., Auricchio A., Barbash I.M., Barrabés J.A., Boriani G., Braunschweig F., Brignole M. et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Europace. 2022;24(1):71-164. doi: 10.1093/europace/euab232;

19. Lombardi C., Faini A., Mariani D., Gironi F., Castiglioni P., Parati G. Nocturnal Arrhythmias and Heart-Rate Swings in Patients With Obstructive Sleep Apnea Syndrome Treated With Beta Blockers. J Am Heart Assoc. 2020;9(21):e015926. doi: 10.1161/JAHA.120.015926;

20. Wolf J., Drozdowski J., Czechowicz K., Winklewski P.J., Jassem E., Kara T., Somers V.K., Narkiewicz K. Effect of beta-blocker therapy on heart rate response in patients with hypertension and newly diagnosed untreated obstructive sleep apnea syndrome. Int J Cardiol. 2016;202:67-72. doi: 10.1016/j.ijcard.2015.08.139.

21. Meszaros M., Mathioudakis A.G., Xanthoudaki, M., Sircu, V., Nena E., Vestbo J., Corlateanu A., Steiropoulos P., Bikov A. The association between beta-blocker therapy and daytime sleepiness in obstructive sleep apnoea. Sleep Biol. Rhythms. 2021;19(4):399–408. doi:10.1007/s41105-021-00330-z.